Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Active Not Recruiting NCT05056545

Postpartum Family Planning Program in Rwanda

Conditions: Family Planning

Sex: All
Healthy volunteers: No
Phase: NA
Enrollment: 38220
Sponsor: Emory University

Location: Project San Francisco, Kigali Kigali Kigali

Summary

This trial wants to address high unmet need for postpartum family planning (PPFP) in Rwanda. A previous pilot study tested the intervention (informed by formative work with couples/clients, clinic providers, champions, and community health workers), which significantly increased the use of PPFP in government clinics. This study now proposes to use an implementation science framework to test the hypothesis that the proposed PPFP intervention is adaptable to large-scale implementation, cost-effective, and sustainable. This PPFP could dramatically reduce unintended pregnancy and abortion and improve birth spacing and maternal and newborn health.

Eligibility Criteria

Inclusion Criteria: * Eligible PPFP promoters will be government facility providers working in ANC,L\&D, IV and/or postpartum services at one of the study facilities. * Eligible PPFP providers will be government facility providers working in L\&D, and/or family planning services at one of the study facilities. * Eligible Happy Client promotors will be postpartum women who received promotions and selected a PPFP method. * Eligible nurse/midwife and CHW promotors will be women working as nurses or CHWs at one of the intervention facilities. * All women eligible for PPFP services in this study will be at any stage of pregnancy or up to 14 weeks postpartum, and receiving antenatal care (ANC), L\&D, IV, or postpartum services at one of the intervention or pilot facilities Exclusion Criteria: * Prisoners

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05056545). StuddyBuddy aggregates publicly available trial information.